Dow Jones Top Company Headlines at 3 PM ET: Anthropic Unveils Paperwork for Blockbuster IPO | Microsoft ...

Dow Jones03:00

Anthropic Unveils Paperwork for Blockbuster IPO

Anthropic filed its IPO paperwork, known as its S-1 filing, giving the world the first official look at details of its business operations and ownership.

----

Microsoft Will Offer Buyouts to 60,000 Employees

The software giant said the buyouts will be available to certain workers in the U.S., U.K., Canada and India.

----

Meta Plans up to $95 Billion in Financing to Power Its AI Growth

The Facebook parent said it would look to raise up to $95 billion to help fund its massive investments in artificial-intelligence infrastructure and personal superintelligence.

----

JetBlue Shares in Tailspin as High Fuel Prices Threaten Turnaround

Executives have said the airline remains confident in its strategy and sees progress in returning to profitability.

----

Verizon Lifts Outlook, Inks Amazon Deal Worth More Than $2 Billion

Verizon boosted its full-year outlook again as it continues to attract new customers. The mobile carrier also signed an AI deal valued at more than $2 billion with Amazon.

----

Bon Secours Affiliate to Acquire Surgery Partners in $5.7 Billion Take-Private Deal

Bain Capital-backed Surgery Partners operates through a network of ambulatory surgery centers, surgical hospitals and physician partnerships.

----

FedEx Hires AutoZone's Jamere Jackson as CFO

FedEx has hired Jamere Jackson as the package-delivery giant's new chief financial officer, plucking the executive from auto-parts retailer AutoZone.

----

EQT to Buy Range Resources in $13 Billion Stock Swap

EQT Corp. has struck a deal to buy Range Resources in a stock swap worth nearly $13 billion that would create a U.S. natural-gas giant.

----

Saudi Arabia's Sabic Profit Rises Despite Lower Sales Volume

The company-one of the world's largest petrochemical manufacturers-reported an increase in net profit even as regional shipping disruptions weighed on sales volumes.

----

Bayer Gets China Approval for Stroke-Prevention Drug in Global First

The authorization to launch Sunharbo in China is the first approval worldwide for a new class of blood-thinning medicines.

----

Roche Targets Emerging Oncology Market With New Lung-Cancer Drug

The drugmaker expects a pill it is developing to become the new standard treatment for an advanced form of lung cancer, and the company's first shot at an emerging field within the oncology market.

----

AstraZeneca Readies New Portfolio of Targeted Cancer Therapies

AstraZeneca is readying to file the first of a new portfolio of targeted cancer drugs for regulatory approval, moving to cement its position in one of the fastest-growing corners of the oncology market.

----

This German Energy Giant Is an Overlooked AI Bargain

Siemens Energy is outselling GE Vernova on gas turbines.

----

Genmab Shares Jump After Positive Cancer Study Results

The Danish biotech said an experimental drug cut the risk of death and disease progression for ovarian-cancer patients in a late-stage clinical trial.

----

Galp Shares Fall After Moeve Merger-Talks Collapse

The stock fell more than 8% after talks with Moeve on a potential downstream combination broke down, overshadowing earnings growth and a full-year guidance hike.

 

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment